Antiviral Effect of Budesonide against SARS-CoV-2
Treatment options for COVID-19, a disease caused by <i>Severe</i> <i>Acute</i> <i>Respiratory</i> <i>Syndrome</i> Coronavirus 2 (SARS-CoV-2) infection, are currently severely limited. Therefore, antiviral drugs that efficiently reduce SARS-CoV-2 replic...
| Published in: | Viruses |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-07-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/13/7/1411 |